セルペルカチニブ
“RET fusions in solid tumors”. Cancer Treat. Rev. 81: 101911. (December 2019). doi:10.1016/j.ctrv.2019.101911. PMID 31715421.
“New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)”. Curr Oncol Rep 22 (5): 48. (April 2020). doi:10.1007/s11912-020-00909-8. PMID 32296961.